Cannabis Ruderalis

Content deleted Content added
Testem (talk | contribs)
See my talk page edits of related cannabinoids for extensive legal breakdowns of related compounds.
Fswitzer4 (talk | contribs)
m Added UNII
Line 24: Line 24:


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref =
| CAS_number = 1400742-15-5
| CAS_number = 1400742-15-5
| CAS_number_Ref = {{cascite|correct|CAS}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3N1P3KD3CV
| ATC_prefix =
| ATC_prefix =
| ATC_suffix =
| ATC_suffix =

Revision as of 16:20, 25 January 2021

CUMYL-PINACA
Legal status
Legal status
Identifiers
  • 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC22H27N3O
Molar mass349.478 g·mol−1
3D model (JSmol)
  • CCCCCN1N=C(C(=O)NC(C)(C)C2=CC=CC=C2)C2=CC=CC=C12
  • InChI=1S/C22H27N3O/c1-4-5-11-16-25-19-15-10-9-14-18(19)20(24-25)21(26)23-22(2,3)17-12-7-6-8-13-17/h6-10,12-15H,4-5,11,16H2,1-3H3,(H,23,26)
  • Key:LCBASRYREGWIJT-UHFFFAOYSA-N

CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.[1]

Legal status

Sweden's public health agency suggested classifying CUMYL-PINACA as a hazardous substance, on November 10, 2014.[2]

See also

References

  1. ^ Dobaja M, Grenc D, Kozelj G, Brvar M (March 2017). "Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA". Clinical Toxicology. 55 (3): 193–195. doi:10.1080/15563650.2016.1278224. PMID 28084855. S2CID 21304629.
  2. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.

Leave a Reply